Claims Targeting Generic Prednisone Preempted, N.Y. Federal Judge Rules

  • Order

NEW YORK — A New York federal judge has dismissed a lawsuit in which a woman alleged her ingestion of Actavis Generics’ prednisone caused her to develop a functional movement disorder, ruling the claims are preempted by federal law.

On Sept. 27, Judge Paul A. Engelmayer of the U.S. District Court for the Southern District of New York agreed with a magistrate judge that Actavis is barred by federal law from unilaterally changing the generic drug’s warning label or design, which is what the plaintiff sought in her pleading.

Pro se plaintiff Nivedita Kulkarni alleged that from April 25 to …


HarrisMartin's Webinar Series: Suboxone (Buprenorphine/Naloxone) Film Marketing, Sales Practices and Products Litigation - MDL No. 3092

December 18, 2023


HarrisMartin's The Art of Litigation Conference: Crafting a Better Practice

November 30, 2023 - Charleston, SC
The Charleston Place